We are live on ! Find out more
CFGS

Concourse Financial Group Securities Portfolio holdings

AUM $1.77B
1-Year Est. Return 17.37%
This Fund
S&P 500
This Quarter Est. Return
+6.03%
1 Year Est. Return
+17.37%
3 Year Est. Return
+18.06%
5 Year Est. Return
+62.97%
10 Year Est. Return
AUM
$1.6B
AUM Growth
+$171M
Cap. Flow
+$92M
Cap. Flow %
5.76%
Top 10 Hldgs %
19.46%
Holding
2,490
New
143
Increased
1,037
Reduced
549
Closed
114
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABR icon
1676
Arbor Realty Trust
ABR
$993M
$18K ﹤0.01%
+1,000
New +$17.6K
DVA icon
1677
DaVita
DVA
$15B
$18K ﹤0.01%
148
-169
-53% -$20K
HRB icon
1678
H&R Block
HRB
$5.73B
$18K ﹤0.01%
749
NWSA icon
1679
News Corp Class A
NWSA
$15.1B
$18K ﹤0.01%
709
+574
+425% +$15.1K
SLX icon
1680
VanEck Steel ETF
SLX
$169M
$18K ﹤0.01%
297
+40
+16% +$2.45K
SPWH icon
1681
Sportsman's Warehouse
SPWH
$44.9M
$18K ﹤0.01%
1,000
STWD icon
1682
Starwood Property Trust
STWD
$5.92B
$18K ﹤0.01%
662
SU icon
1683
Suncor Energy
SU
$77.9B
$18K ﹤0.01%
768
SUN icon
1684
Sunoco
SUN
$14.6B
$18K ﹤0.01%
+478
New +$17K
THC icon
1685
Tenet Healthcare
THC
$20.1B
$18K ﹤0.01%
+266
New +$16.5K
WLK icon
1686
Westlake Corp
WLK
$8.95B
$18K ﹤0.01%
200
XTN icon
1687
State Street SPDR S&P Transportation ETF
XTN
$393M
$18K ﹤0.01%
206
-2,336
-92% -$207K
MTEM
1688
DELISTED
Molecular Templates, Inc.
MTEM
$18K ﹤0.01%
157
-202
-56% -$26.4K
MXIM
1689
DELISTED
Maxim Integrated Products
MXIM
$18K ﹤0.01%
172
-78
-31% -$7.63K
COPX icon
1690
Global X Copper Miners ETF NEW
COPX
$7.36B
$17K ﹤0.01%
+450
New +$17.8K
EQNR icon
1691
Equinor
EQNR
$94.8B
$17K ﹤0.01%
804
+74
+10% +$1.56K
ETG
1692
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.82B
$17K ﹤0.01%
805
IWX icon
1693
iShares Russell Top 200 Value ETF
IWX
$4.02B
$17K ﹤0.01%
257
-418
-62% -$27.7K
LDOS icon
1694
Leidos
LDOS
$14.9B
$17K ﹤0.01%
171
+99
+138% +$10.2K
NXDT
1695
NexPoint Diversified Real Estate Trust
NXDT
$244M
$17K ﹤0.01%
1,206
+55
+5% +$696
REYN icon
1696
Reynolds Consumer Products
REYN
$5.32B
$17K ﹤0.01%
547
+20
+4% +$607
TAK icon
1697
Takeda Pharmaceutical
TAK
$53.7B
$17K ﹤0.01%
1,000
VUZI icon
1698
Vuzix
VUZI
$200M
$17K ﹤0.01%
900
+200
+29% +$4.04K
WOR icon
1699
Worthington Enterprises
WOR
$2.78B
$17K ﹤0.01%
443
+21
+5% +$850
SWAV
1700
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$17K ﹤0.01%
90

Similar funds

Concourse Financial Group Securities's Q2 2021 Portfolio in Review

As of Q2 2021, Concourse Financial Group Securities held 2,490 positions worth $1.6B, up 12% from $1.43B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Concourse Financial Group Securities deployed $92M of net new capital in Q2 2021, opening 143 new positions and adding to 1,037 existing holdings. Its largest new stake was Abacus FCF International Leaders ETF: 167,524 shares worth $5.98M.

By sector, the portfolio is most concentrated in Technology at 7.5% of assets, up from 7.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $7.05M trimmed.

  • Concourse Financial Group Securities's largest Q2 2021 buy was Abacus FCF International Leaders ETF: 167,524 shares worth $5.98M.
  • Concourse Financial Group Securities added most to iShares Core Universal USD Bond ETF in Q2 2021, an estimated $5.43M increase.
  • Concourse Financial Group Securities's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $7.05M.
  • Concourse Financial Group Securities fully exited FT Vest US Equity Deep Buffer ETF August in Q2 2021, selling an estimated $684K.
  • Concourse Financial Group Securities's ten largest holdings make up 19% of its $1.6B portfolio in Q2 2021.
  • Concourse Financial Group Securities opened 143 new positions and closed 114 in Q2 2021.
  • Concourse Financial Group Securities's portfolio value rose 12% quarter-over-quarter to $1.6B.

Based on Concourse Financial Group Securities's 13F filing for Q2 2021, filed 13 Aug 2021.